LEE'S PHARM News

Bocom Intl: rates the Mainland pharmaceutical industry as "leading", focusing on innovative and consumer-driven targets.

Zhitong FinanceOct 17 09:53

Lee's Pharmaceutical Co., Ltd. (0950.HK) Quarterly Report Review: Revenue Growth Speeds Up, R&D News Spreads Frequent

國信證券Dec 3, 2018 00:00

Comments on the quarterly report of Li's Big Pharmaceutical Company (0950.HK): the sales of existing products are accelerated and actively promoted in the research and development pipeline.

光大證券May 28, 2018 00:00

Comments on 0950.HK Annual report: core products get out of the sales bottleneck and continue to increase investment in research and development

國信證券Mar 27, 2018 00:00

李氏大药厂(00950.HK)：进入研发收获期 确定性成长预期不断增强

國信證券Feb 13, 2018 00:00

Lee's Pharmaceutical Company (950.HK): Model adjusted based on first-half results; new target price of HK$8.00

匯富金融Sep 9, 2016 00:00

Comments on the Annual report of Li's Big Pharmaceutical Company (950.HK): the reserve products are rich and the new target price is HK $10.00 for future growth.

匯富金融Apr 5, 2016 00:00

Lee's Pharmaceutical Company (950.HK) Research Briefing: Maintaining a Growth Rate of Over 25% for Seven Consecutive Years

國元(香港)Mar 21, 2014 00:00

Morgan Stanley first "increased its holdings" to Li's Big Pharmaceutical Co. (00950-HK), with the driving force of coordinated growth.

摩根士丹利Feb 7, 2011 15:24